Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

Yuanqi Yong1, Julian Giovannucci1, Sow Neng Pang1

  • 1Monash Health, Clayton, Victoria, Australia.

PubMed

Insights

Higher coronary artery calcium (CAC) density indicates lower cardiovascular disease risk. This finding suggests CAC density can improve risk assessment and prevention strategies for asymptomatic individuals.

Area of Science:

  • Cardiology
  • Radiology
  • Preventive Medicine

Background:

  • Coronary artery calcium (CAC) density is increasingly recognized for its inverse association with plaque vulnerability and atherosclerotic cardiovascular disease (ASCVD) risk.
  • Understanding the predictive value of CAC density is crucial for refining cardiovascular risk assessment.

Purpose of the Study:

  • To systematically review and meta-analyze the predictive value of CAC density for future cardiovascular events.
  • To assess the role of CAC density in asymptomatic individuals undergoing noncontrast CAC scoring computed tomography.

Main Methods:

  • A systematic search of electronic databases identified studies reporting CAC density and subsequent cardiovascular disease (CVD) or coronary heart disease (CHD) events.
  • Random-effects models were used to calculate pooled hazard ratios (HRs) and 95% confidence intervals (CIs).
  • Subgroup analyses stratified by event type (CVD vs. CHD) and statin use were performed.

Main Results:

  • Five studies with six cohorts, totaling 21,346 participants, met the inclusion criteria.
  • Higher CAC density was significantly associated with a lower risk of cardiovascular events (HR: 0.80 per SD; P < 0.01) after adjusting for clinical risk factors and CAC volume.
  • The protective association was observed in both CVD and CHD events and persisted in statin-naive patients, though not significantly in statin-treated patients.

Conclusions:

  • Elevated CAC density is linked to reduced cardiovascular event risk when accounting for established risk factors and CAC volume.
  • CAC density holds potential for enhancing CAC scoring and improving cardiovascular disease risk assessment, treatment, and prevention strategies.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
160
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
27
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
291
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K